By Professor Sallie Pearson

Book Chapters

Karanges EA; Litchfield MJ; Mellish L; Pearson S-A, 2021, 'The Australian Pharmaceutical Benefits Scheme (PBS) Dispensing Database', in Databases for Pharmacoepidemiological Research, Springer Nature, pp. 255 - 266, http://dx.doi.org/10.1007/978-3-030-51455-6_21

, 2014, 'Coriell Personalized Medicine Collaborative: Exploring the Utility of Personalized Medicine', in Handbook of Personalized Medicine, Jenny Stanford Publishing, pp. 1373 - 1418, http://dx.doi.org/10.1201/b15465-31

Langton JM; Pearson SA, 2013, 'Electronic decision support systems for prescribing: Challenges and perspectives for personalized medicine', in Handbook of Personalized Medicine Advances in Nanotechnology Drug Delivery and Therapy, pp. 1439 - 1472, http://dx.doi.org/10.4032/9789814411202

Gordon J; Rolfe I; Pearson S; Willcock S, 1997, 'Assessment of Junior Doctors’ Clinical Competence: A Feedback Loop', in Advances in Medical Education, Springer Netherlands, pp. 474 - 476, http://dx.doi.org/10.1007/978-94-011-4886-3_143

Journal articles

Tuesley KM; Caristo F; Spilsbury K; Pearson SA; Donovan P; Coory MD; Steer CB; Jordan SJ, 2026, 'Nitrogen-Based Bisphosphonate Use and Risk of Cancer in Women Aged 50 Years and Older: A National Data Linkage Study', International Journal of Cancer, 159, pp. 1669 - 1685, http://dx.doi.org/10.1002/ijc.70535

Bonython M; Kalisch Ellett L; Hall K; Carson J; Pearson SA; Pratt N; Janetzki J, 2026, 'Extended dispensing intervals for pancreatic enzyme extract without access destabilisation: a national retrospective study evaluating supply resilience during policy changes and medicine shortages in Australia', Australian Health Review A Publication of the Australian Hospital Association, 50, http://dx.doi.org/10.1071/AH26080

Daniels B; Meagher NS; Ruiz J; Vajdic CM; Gibbs P; Lord SJ; Williams C; Wilson A; Pratt N; Pearson SA, 2026, 'Real-world evidence for the postmarket surveillance of cancer medicines: opportunities and challenges using Australia’s population-based cancer registries', ESMO Real World Data and Digital Oncology, 13, http://dx.doi.org/10.1016/j.esmorw.2026.100748

Camacho X; Schaffer AL; Brett J; Hopkins R; Gisev N; Marsh S; Filion KB; Pratt N; Henry D; Pearson SA, 2026, 'Short-term risk of falls among initiators of controlled-release tapentadol versus oxycodone in New South Wales between 2014 and 2020: A population-based retrospective cohort study', Plos Medicine, 23, pp. e1004950, http://dx.doi.org/10.1371/journal.pmed.1004950

He WQ; Burgner D; Mcmullan B; Britton PN; Bruno C; Todd I; Raubenheimer J; Pearson SA; Nassar N, 2026, 'Antibiotic Use Among Children Before, During, and After the COVID-19 Pandemic: A Nationwide Study', Pediatrics, 158, http://dx.doi.org/10.1542/peds.2025-075481

Ioakeim-Skoufa I; Vicente-Romero J; González-Rubio F; Aza-Pascual-Salcedo M; Laguna-Berna C; Sempere-Verdú E; Vicens-Caldentey C; Palop-Larrea V; Arroyo-Aniés MP; Esteban-Jiménez Ó; Orueta-Sánchez R; Barrio-Díez I; Marín-Murillo P; Pearson SA; Gómez-Vaquero C; Gimeno-Miguel A; Hernández-Rodríguez MÁ, 2026, 'Early dynamics of multimorbidity in 17.4 million people in Spain: onset patterns and prognostic value', European Journal of Public Health, 36, http://dx.doi.org/10.1093/eurpub/ckag067

Varney B; Jones N; Bharat C; Brett J; Degenhardt L; Oei JL; Pearson SA; Havard A; Tran DT, 2026, 'Retention in opioid agonist treatment during pregnancy and variations according to treatment and maternal characteristics', Addiction, 121, pp. 1520 - 1529, http://dx.doi.org/10.1111/add.70325

Hansford HJ; McAuley JH; Swanson SA; Islam N; Dahabreh IJ; Dickerman BA; Egger M; Garcia-Albeniz X; Golub RM; Lodi S; Moreno-Betancur M; Pearson SA; Schneeweiss S; Sterne JAC; Sharp MK; Jones MD; Stuart EA; Lee H; Hernán MA; Cashin AG, 2026, 'The TARGET guideline for reporting observational studies of interventions', Nature Medicine, 32, pp. 1954 - 1955, http://dx.doi.org/10.1038/s41591-026-04358-x

Trofimovs J; Vajdic CM; Srasuebkul P; Pearson SA; Trollor JN, 2026, 'Cancer Incidence in People With Intellectual Disability and Down Syndrome in Australia: A Cohort Study', Cancer Medicine, 15, http://dx.doi.org/10.1002/cam4.71866

Chua KP; Bruno C; Pearson SA; Brett J; He S; Nalliah R; Brummett C, 2026, 'International Trends in Dental Opioid Prescriptions', JAMA Network Open, 9, http://dx.doi.org/10.1001/jamanetworkopen.2026.7824

Daniels B; Tang M; Aslam M; Pearson SA, 2026, 'Polypharmacy among people diagnosed with colorectal cancer in Australia: a population-based cohort study', Oncologist, 31, http://dx.doi.org/10.1093/oncolo/oyaf380

Wang T; Nguyen HL; Tan I; Picone DS; Atkins E; Gnanenthiran SR; Falster MO; Pearson SA; Rodgers A; Schutte AE, 2026, 'Uptake and Costs of the 60-Day Dispensing Policy for Antihypertensive Medicines in Australia: A Mixed Methods Study', Medical Journal of Australia, 224, http://dx.doi.org/10.5694/mja2.70167

Tran DT; Varney B; Jones N; Bharat C; Brett J; Oei JL; Pearson SA; Degenhardt L; Havard A, 2026, 'Trends in Opioid Agonist Treatment for Opioid Dependence During Pregnancy: A Population-Based Study in New South Wales 2005–2021', Drug and Alcohol Review, 45, http://dx.doi.org/10.1111/dar.70139

Hopkins RE; Bharat C; Degenhardt L; Abdel-Shaheed C; Blyth FM; Walpola R; Currow DC; Cashin AG; Demirkol A; Pearson SA; Gisev N, 2026, 'Prescription opioid discontinuation and mortality due to suicide or unintentional overdose', Pain, 167, pp. 469 - 476, http://dx.doi.org/10.1097/j.pain.0000000000003824

Falster MO; de Oliveira Costa J; Milder TY; Carson J; Shadbolt C; Neuen BL; Arnott C; Wilson A; Jun M; Pratt N; Pearson SA, 2026, 'Trends in publicly subsidized and private access to GLP-1 medicines indicated for type 2 diabetes in Australia, 2020–2025', British Journal of Clinical Pharmacology, http://dx.doi.org/10.1002/bcp.70715

Meagher NS; Hewage AH; Daniels B; Ruiz J; Turner V; Friedlander ML; Lee YC; Williams R; Litchfield M; Merritt MA; Defazio A; Cohen PA; Pearson S; Webb P, 2026, '125P Publicly funded testing for germline BRCA1/2 pathogenic variants in ovarian cancer in Australia: A population-based study', ESMO Open, 11, pp. 108172 - 108172, http://dx.doi.org/10.1016/j.esmoop.2026.108172

Araki M; Zoega H; Gillies M; Falster MO; Peiris D; Pearson S-A; Larsson H; de Oliveira Costa J, 2026, 'Cardiovascular Medicine Use Among Adults With ADHD: A Nationwide Study in Australia', Journal of Attention Disorders, 30, pp. 773 - 783, http://dx.doi.org/10.1177/10870547261418763

Zhou Y; Dong Z; Astrup A; Engeland A; Gillies MB; Lunde A; Yuen ASC; Zhang-James Y; Araki M; Brikell I; Gao L; Haavik J; D’Onofrio BM; Sarsembayeva D; Vos M; Wimberley T; Yao H; Dalsgaard S; Faraone SV; Klungsøyr K; Larsson H; Man KKC; Pearson S-A; Wong ICK; Zoega H; Chang Z; Du Rietz E; Snieder H; Hartman CA, 2026, 'Major adverse cardiovascular events and mortality associated with ADHD and its treatment in adults with hypertension: a retrospective, multinational cohort study', The Lancet Primary Care, pp. 100189, http://dx.doi.org/10.1016/j.lanprc.2026.100189

Brikell I; Astrup A; Wimberley T; Araki M; Chang Z; Demontis D; Dong Z; Faraone SV; Gao L; Gillies MB; Haavik J; Hartman C; Larsson H; Man KKC; Pearson S-A; Snieder H; Vos M; Wong ICK; Yao H; Yuen AS; Zhang-James Y; Zhou Y; Zoega H; Engeland A; Dalsgaard S; Klungsøyr K, 2026, 'Psychiatric and neurological predictors of early ADHD medication discontinuation across the lifespan: a multinational study', BMJ Mental Health, 29, pp. e302469, http://dx.doi.org/10.1136/bmjment-2025-302469

Falster M; Shepherd L; Buckley N; Filion K; Daniels B; Schaffer A; Brieger D; Råket H; Milder T; Lin J; Deakin C; de Olivera Costa J; Pearson S, 2026, 'Quantifying the Burden of Potentially Inappropriate Prescribed Medicines Among People Hospitalised With Heart Failure in Australia', Heart Lung and Circulation, 35, pp. s450 - s451, http://dx.doi.org/10.1016/j.hlc.2026.07.676

Falster M; de Oliveira Costa J; Milder T; Carson J; Shadbolt C; Neuen B; Arnott C; Wilson A; Jun M; Pratt N; Pearson S, 2026, 'Trends in Publicly Subsidised and Private Access to GLP-1 Medicines in Australia, 2020–2025', Heart Lung and Circulation, 35, pp. s463 - s464, http://dx.doi.org/10.1016/j.hlc.2026.07.700

Robijn AL; Donald S; Cohen JM; Tran DT; Cesta CE; Furu K; Parkin L; Pearson SA; Reutfors J; Zoega H; Zwar N; Havard A, 2025, 'Effectiveness of smoking cessation pharmacotherapies during pregnancy: A multi-national population-based study', Addiction, http://dx.doi.org/10.1111/add.70290

Bouckley T; Peiris D; Nambiar D; Prince S; Pearson SA; Schierhout G, 2025, '“I would be very proud to be part of an initiative that didn’t exclude people because it was hard”: mapping and contextualising health equity responsibilities and decision-making tensions in the implementation of a multi-level system reform initiative', International Journal for Equity in Health, 24, http://dx.doi.org/10.1186/s12939-025-02405-6

Bouckley T; Peiris D; Nambiar D; Mishra S; Sood T; Purwar P; Elshaug AG; Landon BE; Pearson SA; Huckel Schneider C; Schierhout G, 2025, 'Addressing health equity during design and implementation of health system reform initiatives: a scoping review and framework', International Journal for Equity in Health, 24, http://dx.doi.org/10.1186/s12939-025-02436-z

Domingues A; Zhai Y; Parat MO; Viallon V; Degenhardt L; Pearson SA; Zhou J; Sheikh M, 2025, 'Measuring Exposure to Opioids Using Self-Reported Medication Use Data Versus General Practitioner Prescription Records in the UK Biobank Study', Pharmacoepidemiology and Drug Safety, 34, http://dx.doi.org/10.1002/pds.70280

Sheikh M; Domingues A; Alcala K; Langdon R; Mariosa D; Feng X; Sarich P; Weber MF; Viallon V; Fournier A; Kamangar F; Malekzadeh R; Gillette C; Vitolins MZ; Adams MCB; Virani S; Ebrahimi E; Dudding T; Galesloot TE; Kiemeney LA; Rothman N; Koutros S; Zhou J; Pearson SA; Parat MO; Brennan P; Johansson M; Davey Smith G; Robbins HA, 2025, 'Regular use of pharmaceutical opioids and subsequent risk of cancer: a prospective cohort study and Mendelian randomization analysis', Eclinicalmedicine, 89, http://dx.doi.org/10.1016/j.eclinm.2025.103439

Li AK; Kotwal S; Wallace H; Ketema DB; Wick J; Neuen BL; Falster MO; Lin J; Pearson SA; Peiris D; Jardine MJ; Woodward M; Chalmers J; Ronksley PE; Jun M, 2025, 'Patterns of follow-up testing of abnormal eGFR and UACR for the detection of chronic kidney disease in Australian primary care: analysis of a national general practice dataset', BMJ Open, 15, pp. e096730 - e096730, http://dx.doi.org/10.1136/bmjopen-2024-096730

Wilson BE; Wright K; Sengar M; Sullivan R; Pearson SA; Barton MB; Gyawali B; De Vries E; Moja L; Pramesh CS; Booth CM, 2025, 'Analysis of 2023 World Health Organization cancer Essential Medicines List and concordance with resource-stratified guidelines', Journal of the National Cancer Institute, 117, pp. 2010 - 2020, http://dx.doi.org/10.1093/jnci/djaf100

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; Petoumenos K; George J; Amin J; Matthews GV; Grebely J; Pearson SA; Dore GJ, 2025, 'Corrigendum to “Missed opportunities in HCV care: Trends in late diagnosis and treatment” (JHEP Reports (2025) 7(9), (S2589555925001521), (10.1016/j.jhepr.2025.101474))', Jhep Reports, 7, http://dx.doi.org/10.1016/j.jhepr.2025.101561

de Oliveira Costa J; Gillies MB; Schaffer AL; Zoega H; Peiris D; Pearson SA, 2025, 'New use of antidepressants among Australians up to 24 years of age remains high after the COVID-19 pandemic emergency era', Australian and New Zealand Journal of Psychiatry, 59, pp. 926 - 930, http://dx.doi.org/10.1177/00048674251356404

Wallace H; Wick J; Neuen BL; Buizen L; Badve SV; Chalmers J; de Oliveira Costa J; Falster MO; Ha JT; Jardine MJ; Ketema DB; Lin J; Nelson C; Pearson SA; Peiris D; Rodgers A; Sasaki T; Woodward M; Gallagher M; Kotwal SS; Ronksley P; Jun M, 2025, 'Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset', Diabetes Obesity and Metabolism, 27, pp. 5599 - 5611, http://dx.doi.org/10.1111/dom.16608

Cashin AG; Hansford HJ; Hernán MA; Swanson SA; Lee H; Jones MD; Dahabreh IJ; Dickerman BA; Egger M; Garcia-Albeniz X; Golub RM; Islam N; Lodi S; Moreno-Betancur M; Pearson SA; Schneeweiss S; Sharp MK; Sterne JAC; Stuart EA; McAuley JH, 2025, 'Transparent Reporting of Observational Studies Emulating a Target Trial-The TARGET Statement', JAMA, 334, pp. 1084 - 1093, http://dx.doi.org/10.1001/jama.2025.13350

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; Petoumenos K; George J; Amin J; Matthews GV; Grebely J; Pearson SA; Dore GJ, 2025, 'Missed opportunities in HCV care: Trends in late diagnosis and treatment', Jhep Reports, 7, http://dx.doi.org/10.1016/j.jhepr.2025.101474

Råket HK; Milder T; Litchfield M; Jensen CB; Wang JN; Jimenez-Solem E; Petersen J; Pearson SA; Jaffe A; Falster MO, 2025, 'Reduced Use of Maintenance Therapies Among People With Cystic Fibrosis Following Initiation of Elexacaftor/Tezacaftor/Ivacaftor in Australia', Clinical Therapeutics, 47, pp. 813 - 815, http://dx.doi.org/10.1016/j.clinthera.2025.05.016

de Oliveira Costa J; Lin J; Milder TY; Havard A; Greenfield JR; Day RO; Neuen BL; Gibson AA; Morton JI; Sacre JW; Pearson SA; Falster MO, 2025, 'Variation in uptake of sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor analogues in adults with type 2 diabetes at high cardiovascular risk', European Journal of Clinical Pharmacology, 81, pp. 1315 - 1327, http://dx.doi.org/10.1007/s00228-025-03870-2

MILDER TY; SHEPHERD L; PEARSON S-A; KRISTIAN RÅKET H; GREENFIELD J; DAY RO; LIN J; POLLOCK CA; NEUEN B; JUN MIN; DE OLIVEIRA COSTA J; STOCKER S; LUDINGTON J; FALSTER MO, 2025, '904-P: Hospitalization Is a Risk Factor for SGLT2i Discontinuation', Diabetes, 74, http://dx.doi.org/10.2337/db25-904-p

Tran DT; Cohen JM; Donald S; Cesta CE; Furu K; Parkin L; Pearson SA; Reutfors J; Robijn AL; Zoega H; Zwar N; Havard A, 2025, 'Risk of Major Congenital Malformations Following Prenatal Exposure to Smoking Cessation Medicines', JAMA Internal Medicine, 185, pp. 656 - 667, http://dx.doi.org/10.1001/jamainternmed.2025.0290

Ho CLB; Youens D; Abhayaratna WP; Bulsara MK; Hughes J; Moorin R; Pearson SA; Preen DB; Reid CM; Ruiter R; Saunders CM; Stricker BH; Stubbs J; van Rooij FJA; Wright C; Ha NT, 2025, 'Estimation of the Duration of Antihypertensive Prescriptions: Validation of a Data-Driven Approach Using Rotterdam Study Data', Pharmacoepidemiology and Drug Safety, 34, http://dx.doi.org/10.1002/pds.70164

Lin J; Milder TY; Deakin CT; de Oliveira Costa J; Havard A; Neuen BL; Buckley NA; Brieger D; Greenfield JR; Jun M; Day RO; Pearson SA; Falster MO, 2025, 'Trends in use of sodium-glucose cotransporter 2 inhibitors among people with type 2 diabetes following hospitalisation with heart failure: A population-based study', Diabetes Research and Clinical Practice, 224, pp. 112242, http://dx.doi.org/10.1016/j.diabres.2025.112242

Tuesley KM; Spilsbury K; Pearson SA; Donovan P; Obermair A; Coory MD; Ali S; Pandeya N; Stewart L; Jordan SJ; Webb PM, 2025, 'Long-acting, progestin-based contraceptives and risk of breast, gynecological, and other cancers', Journal of the National Cancer Institute, 117, pp. 1046 - 1055, http://dx.doi.org/10.1093/jnci/djae282

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; George J; Matthews G; Grebely J; Pearson SA; Dore GJ, 2025, 'Trends in cause-specific mortality among people with hepatitis C virus in New South Wales, Australia', International Journal of Drug Policy, 139, http://dx.doi.org/10.1016/j.drugpo.2025.104790

Deakin CT; Costa JDO; Brieger D; Lin J; Schaffer AL; Kidd M; Pearson SA; Falster MO, 2025, 'Post-discharge pharmacotherapy in people with atrial fibrillation hospitalized for acute myocardial infarction: an Australian cohort study 2018-22', European Heart Journal Quality of Care and Clinical Outcomes, 11, pp. 259 - 270, http://dx.doi.org/10.1093/ehjqcco/qcae068

Bruno C; Cesta CE; Hjellvik V; Ulrichsen SP; Bjørk MH; Esen BÖ; Gillies MB; Gissler M; Havard A; Karlstad Ø; Leinonen MK; Nørgaard M; Pearson SA; Reutfors J; Furu K; Cohen JM; Zoega H, 2025, 'Corrigendum to Antipsychotic use during pregnancy and risk of specific neurodevelopmental disorders and learning difficulties in children: a multinational cohort study [eClinicalMedicine 70 (2024) 102531/DOI: 10.1016/j.eclinm.2024.102531] (eClinicalMedicine (2024) 70, (S258953702400110X), (10.1016/j.eclinm.2024.102531))', Eclinicalmedicine, 81, http://dx.doi.org/10.1016/j.eclinm.2025.103139

Milder TY; Lin J; Pearson SA; de Oliveira Costa J; Neuen BL; Pollock C; Jun M; Greenfield JR; Day RO; Stocker SL; Brieger D; Falster MO, 2025, 'Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?', Diabetes Obesity and Metabolism, 27, pp. 997 - 1000, http://dx.doi.org/10.1111/dom.16061

Crepalde-Ribeiro K; Braga MDG; Silveira MR; Moura AS; Vaz-de-Melo POS; Ferraz MMD; Pearson SA; Costa JDO, 2025, 'Non-adherence, discontinuation, and seroconversion among people on daily HIV pre-exposure prophylaxis (PrEP) in Brazil: a nationwide cohort study', AIDS Care Psychological and Socio Medical Aspects of AIDS HIV, 37, pp. 289 - 299, http://dx.doi.org/10.1080/09540121.2024.2443824

Campbell G; Tran DT; Bharat CI; Degenhardt L; Draper B; Pearson SA; Gisev N; Havard A, 2025, 'Risk of self-harm and suicide associated with the use of opioid analgesics', British Journal of Psychiatry, http://dx.doi.org/10.1192/bjp.2025.10436

Back to profile page